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Abstract: This work describes peptides from non-structural proteins (nsp) of porcine 
reproductive and respiratory syndrome virus (PRRSV) predicted as potential T cell 
epitopes by bioinfornatics and tested for their ability to induce IFN-γ and IL-10 responses. 
Pigs immunized with either genotype 1 or genotype 2 PRRSV attenuated vaccines 
(n=5/group) and unvaccinated pigs (n = 4) were used to test the peptides. Swine leukocyte 
antigen haplotype of each pig was also determined. Pigs were initially screened for IFN-γ 
responses (ELISPOT) and three peptides were identified; two of them in non-conserved 
segments of nsp2 and nsp5 and the other in a conserved region of nsp5 peptide.  
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Then, peptides were screened for IL-10 inducing properties. Six peptides were found to 
induce IL-10 release in PBMC and some of them were also able to inhibit IFN-γ responses 
on PHA-stimulated cells. Interestingly, the IFN-γ low responder pigs against PRRSV were 
mostly homozygous for their SLA haplotypes. In conclusion, these results indicate that nsp 
of PRRSV contain T-cell epitopes inducing IFN-γ responses as well as IL-10 inducing 
segments with inhibitory capabilities. 
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1. Introduction 
Porcine reproductive and respiratory syndrome (PRRS) is one of the most costly diseases of  
swine [1]. This syndrome is caused by PRRS virus (PRRSV), that belongs to the family Arteriviridae 
in the order Nidovirales and comprises two different genotypes named type 1 (formerly called 
European) and type 2 (formerly called North-American) [2,3]. PRRSV has a positive-stranded RNA 
genome of about 15 Kb organized in 10 open reading frames (ORF). ORF1a and 1b encode for two 
polyproteins that after enzymatic cleavage will result in 14 non-structural proteins (nsp) involved in 
viral replication. ORF2-ORF7 encode the structural proteins of the virus [4,5]. Non-structural proteins, 
particularly nsp2, have been shown to contain some dominant linear B epitopes [6–8]. Also, nsp1, 
nsp2, nsp4 and nsp11 have been related to the inhibition of type I IFNs and nsp2 may be also involved 
in the viral regulation of TNF-α responses of the host cell [9,10]. In PRRSV infection, IL-10 seems to 
be up-regulated in PBMC and dendritic cells [11,12] and its expression could be inversely related to  
IFN-γ responses [13]. These inhibitory effects have been related to the ability of PRRSV to evade the 
immune response of pigs. Structural proteins contain neutralization epitopes that have been reported to 
exist in glycoproteins (GP) 2, 3, 4, 5 and protein M although the role of GP5 in the induction of 
neutralizing antibodies is debated nowadays [14–16].  
PRRSV control has proven to be difficult, among other causes because immunity against one strain 
does not preclude protective immunity against a different one [17–19]. The ideal of a universally 
effective vaccine, namely, one that could protect against all existing PRRSV strains, is far from reach. 
Broadly reactive T- and B- epitopes that could elicit T-cell responses and neutralizing antibodies 
against all, or at least a majority of PRRSV strains have not been clearly identified. Identification of 
such epitopes is therefore a key element for the development of PRRSV vaccinology. 
IFN-γ responses have been related with clearing of PRRSV infection [20,21]; therefore, it is 
important to find relevant regions of the virus that induce IFN-γ responses. In the past, some epitopes 
inducing IFN-γ have been described among structural proteins [22–24]. At the moment, there is only 
one paper reporting the role of nsp (nsp9 and nsp10) in the induction of T-cell responses [25]. 
Bioinformatic prediction is a method to screen for potentially relevant T-cell epitopes based on binding 
to major histocompatibility complex (MHC)-I or MHC-II. Selected peptides have to be tested then by 
methods such as the IFN-γ ELISPOT or others to corroborate the prediction. In spite of its limitations 
compared with other methods—for example evaluation of overlapping peptides—prediction allows the 
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detection of immunodominant T-cell epitopes from several proteins in an easy and cheap way. In this 
study we used bioinformatics for the screening of immunodominant T-cells epitopes in conserved and 
non-conserved segments of nsp of genotype 1 and 2 of PRRSV. The manuscript reports that certain 
peptides within nsp of PRRSV may induce IFN-γ responses in PBMC while others induce recall or 
natural IL-10 release. The ability of the identified IL-10 inducing peptides for inhibiting IFN-γ 
responses in naïve and PRRS vaccinated pigs was examined. 
2. Results and Discussion 
2.1. Peptide-Induced IFN-γ Producing Cells 
Usually, variation in nsp is limited because of the essential nature of their functionalities for viral 
replication. T-epitopes present in conserved regions of nsp would be therefore excellent candidates for 
a “universal” vaccine. Recently it was reported that peptides of nsp9 and nsp10 of PRRSV were able to 
induce IFN-γ recall responses [25]. In the present work we screened conserved or non-conserved 
regions of nsp2, nsp3, nsp5, nsp9 nsp10 of PRRSV for potential T-cell epitopes by using 
bioinformatics. The examined peptides were composed by: a) the 18 best scoring peptides located in 
conserved regions of nsp for both viral genotypes; b) the six best scoring peptides with conservation 
values between 80% and 90% and, c) the four best scoring peptides in nsp of each genotype regardless 
of their degree of conservation (Table 1).  
IFN-γ responses were evaluated in the ELISPOT at 21 and 49 dpv. At 21 dpv IFN-γ responses were 
very low increasing substantially at 49 dpv; Table 2 shows the results at 49 dpv. Frequencies of IFN-γ 
secreting cells against conserved peptides of non-structural proteins of PRRSV were poor, while the 
IFN-γ response against non-conserved peptides with high prediction scores was clearly present.  
In group I (vaccinated with the genotype 1 vaccine), 3/5 pigs responded consistently to a non-
conserved nsp2 peptide (aa 589-597 SLYKLLLEV). Other three peptides (the non-conserved aa 1114-
1149 WLFAGVVLL in nsp2, the conserved aa 1929-1937 LLNEILPAV and the non-conserved aa  
2025-2033 IIIGGLHTL, both in nsp5) were recognized by 2/5 pigs. For genotype 2 vaccinated pigs, 
the response was general of lower intensity. IFN-γ frequencies were only observed in 2/5 pigs for two 
peptides (aa 589-597 SLYKLLLEV) in nsp2 and one conserved in nsp5 (aa 1929-1937 LLNEILPAV). 
The frequency of IFN- in presence of virus was higher in pigs of group I compared with pigs of group 
II. Unvaccinated pigs did not respond to any peptide or whole virus. 
Compared to the use of overlapping peptides, the bioinformatic approach permit to reduce the costs 
associated to the production of large number of peptides. Certainly, one common criticism to the 
bioinformatics approach is about sensitivity. When applied to pigs, the lack of predictive tools based 
on porcine SLA is also a problem. Regarding the first issue, in the present study we included not only 
the peptides with the best prediction scores within conserved regions of PRRSV nsp but also, the four 
peptides with the best prediction scores in non-conserved regions of nsp of genotype 1 and 2 PRRSV. 
This should serve to assess the sensitivity of the method. As shown by the results, the method of 
prediction was sensitive and accurate enough to allow the identification of peptides able to induce  
IFN-γ comparable with those reported by others in structural proteins [22,23]. The best peptide 
identify in this work was classified as non-conserved (aa 589-597 SLYKLLLEV), which led us to 
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suggest that conserved segments of nsp are not very good candidates for a potentially universal 
PRRSV vaccine; although the role of conserved aa 1929-1937 LLNEILPAV should be further 
investigated. In any case, it cannot be discarded that other T-epitopes in conserved regions of PRRSV 
nsp could exist and were not detected by the methodology and techniques used here. 
Table 1. Peptides predicted as T-cell epitopes of non-structural proteins (nsp) of porcine 
reproductive and respiratory syndrome virus (PRRSV) analyzed in the present study. 
Protein aa position Predicted sequence Conservation 
a
 
nsp2 589-597 SLYKLLLEV No 
nsp2 1061-1069 GRFEFLPKM No 
nps2 1141-1149 WLFAGVVLL No 
nsp3 1337-1345 YIWHFLLRL No 
nsp3 1670-1678 AVRRAALTG Yes 
nsp5 1902-1910 VQLLCVFFL Yes 
nsp5 1929-1937 LLNEILPAV Yes 
nsp5 1960-1968 VLMIRLLTA No 
nsp5 2025-2033 IIIGGLHTL No 
nsp5 2046-2054 ILNEVLPAV Yes 
nsp9 3-11 FKLLAASGL No 
nsp9 142-150 QLPYKLYPV Yes 
nsp9 143-151 FVLPGVLRL Yes 
nsp9 246-254 MAGINGQRF Yes 
nsp9 246-254 MAGINGNRF Yes 
nsp9 258-266 VLPGVLRLV No 
nsp9 325-333 TVTPCTLKK Yes 
nsp9 377-385 LGKNKFKEL Yes 
nsp9 430-438 YVLNCCHDL Yes 
nsp9 524-532 NYHWWVEHL Yes 
nsp9 587-595 YYASAAAIL Yes 
nsp9 594-602 ILMDSCACI Yes 
nsp9 1222-1230 YLPSYVLNC Yes 
nsp10 670-678 VPYKPPRTV Yes 
nsp10 716-724 IPYKPPRTV No 
nsp10 718-726 YKPPRTVIM Yes 
nsp10 974-982 ITIDSSQGA Yes 
nsp11 1116-1124 KELAPHWPV Yes 
nsp11 1116-1124 VELAPHWPV Yes 
nsp11 1166-1174 GTPGVVSYY No 
nsp11 1222-1230 YLPDLEAYL No 
aa = amino acid; 
a 
Those peptides with a maximum of one 
amino acid of difference between the examined sequences 
were considered as conserved between genotypes.
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Table 2. Frequencies of IFN-γ secreting cells per 5 × 105 PBMC (ELISPOT) induced by peptides of non-structural proteins of PRRSV.  
The table shows only peptides resulting in an adjusted count of at least  ≥5 spots/well (cut-off of the test) for one or more pigs. 
Protein aa position Peptide sequence 
 Group Ia (pig nº)  Group II (pig nº)  Group III (pig nº) 
 66 67 68 69 70  61 62 63 64 65  71 72 73 74 
nsp2 589-597 SLYKLLLEV  1 14 10 0 9  0 5 9 0 1  0 0 0 0 
nsp2 1061-1069 GRFEFLPKM  0 3 0 0 0  0 4 7 3 3  0 0 0 0 
nsp2 1141-1149 WLFAGVVLL  2 10 3 0 11  0 13 7 0 0  0 1 0 0 
nsp3 1337-1345 YIWHFLLRL  2 5 5 0 3  0 2 5 0 2  0 0 1 0 
nsp5 1929-1937 LLNEILPAV  2 8 0 0 7  0 9 17 0 0  0 0 0 0 
nsp5 2025-2033 IIIGGLHTL  2 13 5 0 9  0 6 2 0 2  0 0 0 0 
nsp5 2046-2054 ILNEVLPAV  2 8 1 0 5  0 0 5 0 2  0 0 1 0 
nsp9 246-254 MAGINGNRF  0 8 0 0 0  0 0 0 0 1  2 0 1 0 
nsp9 587-595 YYASAAAIL  0 6 0 0 0  0 1 0 0 0  0 0 0 0 
nsp11 1116-1124 VELAPHWPV  0 12 0 0 0  0 0 0 0 0  0 0 0 0 
nsp11 1116-1124 KELAPHWPV  0 10 3 0 1  0 0 0 0 0  0 0 0 0 
nsp11 1166-1174 GTPGVVSYY  0 5 0 0 0  0 0 0 0 0  0 0 0 0 
nsp11 1222-1230 YLPDLEAYL  1 2 31 0 0  0 4 7 0 0  0 0 0 0 
 Genotype 1 whole virus  42 29 96 0 17  0 10 12 0 2  0 0 0 0 
 Genotype 2 whole virus  0 1 6 0 14  5 7 2 0 0  0 0 0 0 
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Table 3. Swine leukocyte antigen (SLA) class I and class II low-resolution (Lr) haplotypes identified by PCR-SSP in pigs included in the 
present study. Identification numbers 61-70 correspond to vaccinated pigs and numbers pigs 71–74 correspond to naïve unvaccinated controls. 
 SLA class I SLA class II 
Pig n° SLA-1 SLA-2 SLA-3 
Inferred 
haplotype 
DQA DQB1 DRB1 
Inferred 
haplotype 
61 04XX 04XX 04XX/hb06 Lr-04.0 04XX+w05XX 09XX 09XX/La02 Lr-0.27 
 11XX (1103) jh02 05XX Lr-59.0 02XX/ka01 Blank 06XX Lr-0.32 
62 04XX 01XX 01XX Lr-LD-01.0 01XX 07XX 06XX Lr-0.12 
 blank 05XX 06XX (0601) Lr-47.0 03XX 07XX 04XX Lr-0.19a 
63 04XX 04XX 04XX/hb06 Lr-04.0 02XX/ka01 04XX 02XX Lr-0.04 
 13XX 10XX 05XX Lr-64.0 01XX 06XX/zs12 10XX Lr-0.23 
64 04XX 04XX 04XX/hb06 Lr-04.0 02XX/ka01 04XX 02XX Lr-0.04 
 04XX 04XX 04XX/hb06 Lr-04.0 02XX/ka01 04XX 02XX Lr-0.04 
65 04XX 04XX 04XX/hb06 Lr-04.0 04XX+w05XX 09XX 09XX/La02 Lr-0.27 
 11XX (1103) jh02 05XX Lr-59.0 02XX/ka01 Blank 06XX Lr-0.32 
66 09XX 05XX 07XX Lr-28.0 01XX 06XX/zs12 10XX Lr-0.23 
 11XX (1103) jh02 05XX Lr-59.0 04XX+w05XX 09XX 09XX/La02 Lr-0.27 
67 04XX 04XX 04XX/hb06 Lr-04.0 02XX/ka01 02XX 04XX Lr-0.15a 
 11XX (1103) jh02 05XX Lr-59.0 04XX+w05XX 09XX 09XX/La02 Lr-0.27 
68 04XX 01XX 01XX Lr-LD-01.0 01XX 07XX 06XX Lr-0.12 
 blank 05XX 04XX/hb06 Lr-34.0 04XX+w05XX 09XX 13XX Lr-0.25 
69 04XX 04XX 04XX/hb06 Lr-04.0 02XX/ka01 02XX 04XX Lr-0.15a 
 04XX 04XX 04XX/hb06 Lr-04.0 02XX/ka01 02XX 04XX Lr-0.15a 
70 01XX 01XX 01XX Lr-01.0 01XX 01XX 01XX Lr-0.01 
 11XX (1103) jh02 05XX Lr-59.0 04XX+w05XX 09XX 09XX/La02 Lr-0.27 
71 04XX 01XX 01XX Lr-LD-01.0 01XX 07XX 06XX Lr-0.12 
 blank 05XX 04XX/hb06 Lr-34.0 01XX 07XX 06XX Lr-0.12 
72 04XX 04XX 04XX/hb06 Lr-04.0 02XX 04XX 11XX Lr-0.26 
 11XX (1103) jh02 05XX Lr-59.0 04XX+w05XX 09XX 09XX/La02 Lr-0.27 
73 04XX 04XX 04XX/hb06 Lr-04.0 01XX 06XX/zs12 10XX Lr-0.23 
 11XX (1103) jh02 05XX Lr-59.0 04XX+w05XX 09XX 09XX/La02 Lr-0.27 
74 04XX 04XX 04XX/hb06 Lr-04.0 01XX 06XX/zs12 10XX Lr-0.23 
 11XX (1103) jh02 05XX Lr-59.0 04XX+w05XX 09XX 09XX/La02 Lr-0.27 
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Parida et al. [25] have reported two peptides from nsp9 and two peptides from nps10 as IFN-γ 
inducers. In our work, frequencies of IFN-γ secreting cells in response of nsp9 and nsp10 were low or 
nil and, in most cases, did not reach the minimum value (>5 spots) to be considered significant. The 
reason for these apparently contradicting results may reside firstly in the different approach 
(overlapping peptides versus prediction). Secondly, with the aim of having high specificity, the criteria 
set by us for identifying IFN-γ inducing peptides required adjusted counts in ELISPOT of  
>5 spots/well and at least 2/5 pigs having positive responses and therefore, some lowly reacting 
peptides could have been missed. As a matter of fact, nsp9 peptide aa 524-532 NYHWWVEHL 
examined by us overlapped with one of the peptides identified by Parida et al. [25] in positions  
519-535 of that protein. In our case, individual responses in ELISPOT for that peptide were always 
below 5 counts. As evidenced in the present and other studies [22–25] individual variations attributable 
to pigs can have an influence on the results regardless of the approach taken.  
Next we analyzed SLA class I and class II haplotypes of pigs used in the experiment by PCR-based 
method using allele-group sequence-specific primers (PCR-SSP). The unresponsive pig in group I  
(pig 69) and one of the unresponsive group II (pig 64) were the only two animals being homozygous 
for SLA-I and SLA-II (Table 3). Although the number of examined pigs was not enough to establish 
clear correlations, it is interesting to note that SLA class I and class II homozygous pigs showed very 
poor IFN-γ to PRRSV suggesting that perhaps those animals had a very restricted panel of potentially 
recognizable epitopes. On the other hand, two of the high responders (pig 62 and 68) corresponded to  
a newly described haplotype and other high responders for genotype 1 or 2 vaccines (pigs 62, 66, 67, 
70) share class I haplotype Lr-59.0 and class II haplotype Lr-0.27. Investigation of the relationship 
between haplotypes and response to PRRSV would merit further studies. 
2.2. Evaluation of Peptide-Induced TGF-β and IL-10 Responses of PBMC 
Since most peptides did not induce IFN-γ responses in immunized pigs, the question of whether or 
not those peptides have the capability to induce other cytokines such as TGF-β and IL-10 remained 
open. We decided to evaluate the ability of those peptides to induce other responses such as TGF-β and 
IL-10 release. Results did not support that any of the examined peptides induced TGF-β (data not 
shown); in contrast, some peptides induce IL-10 (Table 4). For this screening, it was considered 
positive those peptides inducing IL-10 release in PBMC cultures if two or more pigs of a group.  
Table 4 shows peptides that induce IL-10. Peptides that did not induce IL-10 (peptide aa 246-254 
MAGINGQRF from nsp9, aa 1222-1230 YLPSYVLNC from nsp11, aa 3-11 FKLLAASGL from 
nsp9, and aa 2025-2033 IIIGGLHTL from nsp5) were no include in this table. Peptide aa 589-597 
SLYKLLLEV of nsp2, which has been previously identified a IFN- inducer (Table 2), was not able to 
induce IL-10. This suggests that this is a peptide that needs more investigation to prove their 
participation in immunity and protection. In contrast, peptide aa 1929-1937 LLNEILPAV of nsp5 that 
induced IFN- was also a strong inducer of IL-10. These are not necessarily contradictory facts. For 
example, it have been reported that in Hepatitis C virus the same peptide can induce Th1 and 
regulatory responses [26]. The rest of the peptides induce the production of IL-10, and only peptide, aa 
1116-1124 KELAPHWPV of nsp11, induce IL-10 in a similar way that peptide aa 1929-1937 
LLNEILPAV of nsp5. It would be interesting to test whether or not the IL-10 inducing peptides 
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identified here contribute or not to the development of Treg. Interestingly, peptide 
SNLQLIYNLTLCELNGTDWL that had been previously reported as potential inducer of T regulatory 
cells (Treg) [27], was also IL-10 inducer.  
2.3. Inhibition of IFN-γ Responses by Peptides 
The observation that some peptides were able to induce IL-10 responses leads us to examine if 
those peptides were able to inhibit IFN-γ responses induced by PHA. The experiments aimed to test 
the inhibition of IFN-γ responses showed that peptide aa 1116-1124 KELAPHWPV (a conserved 
peptide in nsp11) produced a significant reduction in the frequencies of IFN-γ secreting cells after 
PHA stimulation in 2/3 vaccinated and 2/3 unvaccinated pigs. Peptide aa 1929-1937 LLNEILPAV  
(a conserved peptide in nsp5) reduced the frequencies of PHA-induced IFN-γ secreting cells in  
2/3 unvaccinated pigs and 1/3 vaccinated ones. The rest of the peptides tested produced inhibition in 
just one unvaccinated and one vaccinated pig, respectively (Table 5). 
As show the results, when in the IFN-γ ELISPOT peptides were added to PBMC cultures 
stimulated with PHA inhibiting peptides were identified. Thus, two conserved peptides (aa 1116-1124 
KELAPHWPV in nsp11 and aa 1929-1937 LLNEILPAV in nsp5) were able to inhibit significantly the 
frequencies of IFN-γ secreting cells in response to PHA regardless of whether the pigs were vaccinated 
or not. Therefore, this inhibition was not related to recall responses and suggest that this is probably an 
intrinsic property of most –or all- PRRSV strains. These results suggest that PRRSV may potentially 
inhibit IFN-γ responses, coincidentally, nsp11 is a protein known for their potential to inhibit also the 
expression of type I IFN [9]. 
3. Experimental Section  
3.1. Experimental Design 
Deduced amino acid sequences of polyproteins encoded by ORFs 1a and 1b of PRRSV genotype 1 
[Genbank: M96262] were scanned for the detection of potential T-cell epitopes using bioinformatic 
prediction methods. Conservation of the predicted peptides was determined by comparison with a set 
of PRRSV sequences of genotype 1 and 2 isolates (n=40). Then, a set of the 18 best scoring conserved 
peptides (those peptides with one or none amino acid changes between genotype 1 and 2 isolates) and 
six non-conserved peptides (those peptides for which two or more amino acid changes between 
genotype 1 and 2 isolates were observed) were tested for their ability to induce IFN-γ responses in 
PBMC of immunized pigs. Additionally, the four best potential T-cell epitopes in nsp of prototype 
strains of genotype 1 and 2 -regardless of whether or not they were conserved- were tested. Also, the 
ability of the peptides for inducing IL-10 and TGF-β secretion in PBMC was examined. Peptides 
inducing IL-10 responses were further tested for their ability to inhibit IFN-γ responses in PBMC of 
vaccinated and unvaccinated pigs.  
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Table 4. IL-10 levels (pg/mL) as determined by ELISA in cell culture supernatants of PBMC of PRRSV-vaccinated and unvaccinated pigs 
after stimulation with different peptides (10 µg/mL) of non-structural proteins of PRRSV. The table only shows peptides inducing IL-10 
release in PBMC cultures of at least one pig. 
Protein aa position Peptide sequence 
 Pigs of group I  Pigs of group II  Pigs of group III 
 66 67 68 69 70  61 62 63 64 65  71 72 73 74 
nsp2 589-597 SLYKLLLEV  0 0 0 0 0  0 0 0 0 0  0 0 58 0 
nsp2 1061-1069 GRFEFLPKM  70 0 0 0 37  0 0 0 0 0  0 0 0 0 
nsp2 1141-1149 WLFAGVVLL  55 0 0 0 33  0 0 0 0 0  0 33 0 0 
nsp3 1337-1345 YIWHFLLRL  0 0 49 40 0  0 0 0 0 0  0 0 42 0 
nsp5 1929-1937 LLNEILPAV  82 0 50 0 33  0 0 0 0 0  0 41 34 0 
nsp9 258-266 VLPGVLRLV  111 0 55 35 63  34 0 0 0 0  0 0 0 0 
nsp10 716-724 IPYKPPRTV  0 0 51 0 35  0 0 0 0 0  0 0 43 0 
nsp10 974-982 ITIDSSQGA  89 0 31 33 0  0 0 0 0 0  0 0 58 0 
nsp11 1116-1124 KELAPHWPV  90 0 0 37 0  0 0 0 0 0  0 43 51 0 
nsp11 1166-1174 GTPGVVSYY  43 0 0 44 36  0 0 34 0 0  0 0 0 0 
ORF5 37-56 SNLQLIYNLTLCELNGTDWL  63 0 0 0 46  0 0 0 0 0  0 62 40 74 
 Genotype 1 whole virus  218 0 0 50 48  0 0 0 0 0  0 34 72 33 
 Genotype 2 whole virus  0 0 0 0 0  0 0 0 0 0  0 0 0 0 
 PHA  88 117 86 60 52  45 130 137 54 73  375 63 96 40 
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Table 5. Effect of the addition of selected peptides to PHA-stimulated cultures on the 
frequency of IFN-γ secreting cells (per 5x104 cells) of PBMC as determined in ELISPOT. 
 
 Group I Group II Group III 
Pig no. 66 68 61 71 73 74 
PHA only (10 μg/ml) 52 ± 3 49 ± 1 27 ± 3 73 ± 12 40 ± 5 50 ± 6 
 
Protein aa position Peptide sequence PHA (10 μg/mL) plus peptide (10 μg/ml) 
nsp2 1061–1069 GRFEFLPKM 54 ± 10 N.D. N.D. 71 ± 12 N.D. 40 ± 4 
nsp5 1929–1937 LLNEILPAV 35 ± 6* 39 ± 12 20 ± 14 70 ± 0 23 ± 8* 39 ± 14* 
nsp9 258–266 VLPGVLRLV 44 ± 3 N.D. N.D. 79 ± 4 N.D. 22 ± 4* 
nsp11 1166–1174 GTPGVVSYY 35 ± 16* N.D. N.D. 83 ± 6 N.D. 38 ± 2 
nsp11 1116–1124 KELAPHWPV 31 ± 0* 17 ± 7* 19 ± 5 67 ± 5 25 ± 7* 31 ± 6* 
ORF5 37–56 SNLQLIYNLTLCELNGTDWL 28 ± 5* 45 ± 6 22 ± 4 66 ± 0 40 ± 3 32 ± 2* 
N.D: Not determined; *p < 0.05 (Conover-Inman test) 
3.2. Bioinformatic Prediction of Potential T-Cell Epitopes and Peptide Synthesis 
Prediction of potential T-epitopes was carried out according to Diaz et al. [23] The predicted 
translation of ORFs 1a and 1b of Lelystad virus [genotype 1 prototype, Genbank: M96262] was used 
as a template for the screening. Briefly, prediction of nonamers binding to MHC-I was done with 
SYFPEITHI [28]. And for nonamers binding to MHC-II, the prediction was done using ProPred [29]. 
Peptides with the higher scores on SYFPEITHI and ProPred were further analyzed to assess the 
dissociation values (IC50 < 50 nM) using an online calculation tool [30]. Nonamers with the highest 
prediction scores and with the lowest dissociation values (IC50 < 50 nM) were chosen. The location of 
the predicted potential T-cell epitopes in the different non-structural proteins of PRRSV was 
determined using an alignment of polyproteins 1a and 1b of Lelystad virus and other eight genotype 1 
isolates [Genbank: AY366525, AY588319, DQ489311, FJ349261, GU047344, GU047345, 
GU737264, JF802085, and M96262] and 31 genotype 2 sequences including prototype 2 strain  
VR-2332 [Genbank: AF176348, AY262352, AY545985, DQ459471, EF153486, EF635006, 
EU262603, EU360128, EU807840, EU860248, EU860249, EU880433, EU880438, FJ175687, 
GQ499193, GU232736,HQ401282, JF268682, JN626287, JN864948, JQ308798, JQ309822, 
JQ326271, JQ663556, JQ663568, JQ715697, JQ743666, JQ804986, NC_001961, and U87392].  
Peptides located in conserved regions -at maximum one amino acid of difference between 
genotypes- that met the prediction criteria mentioned above were selected (nine peptides binding to 
MHC-I and nine binding to MHC-II). For four peptides having one amino acid of difference between 
genotypes, both variants were examined.  
Additionally, six best-scoring peptides with conservation between 80%–90% were included (two 
binding to MHC-I and four binding to MHC-II). Additionally, the four best scoring peptides binding to 
MHC-I in non-conserved regions for genotype 1 and genotype 2 PRRSV strains were selected.  
Also, a peptide previously reported to potentially induce regulatory T-cells (Tregs) was also  
included [27] Predicted peptides were produced by GL Biochem Ltd (Shangai, China) at a purity of ≥ 
95% and adjusted to a concentration of 1mg/ml (master solution) in water or 50% methanol. Table 1 
shows the peptides included in the present study. 
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3.3. Animals, Swine Leukocyte Antigen (SLA) Haplotyping and Vaccination 
Four week-old piglets (n=14) were obtained from a PRRSV-free farm. Animals were confirmed to 
be sero-negative to PRRSV by ELISA at the beginning of the experiment (Herdchek X3, IDEXX 
Laboratories Inc). Animals were genotyped for their swine leukocyte antigen (SLA) haplotypes by 
running low-resolution PCR screening assays (PCR-SSP) on PBMC-derived genomic DNA as 
described by Essler et al. [31]. Animals were housed in the experimental farm of the Universitat 
Autònoma de Barcelona. At reception, pigs were ear-tagged and randomly (random numbers) 
distributed in three separated pens (designated as group I, n=5; group II, n=5 and; group III, n=4) 
where they were left to acclimatize for five days. Group I pigs were vaccinated with a commercial 
genotype 1 live attenuated PRRSV vaccine (Porcilis PRRS, Merck); group II was vaccinated with a 
genotype 2 live attenuated PRRSV vaccine (Ingelvac PRRS MLV, Boehringer-Ingelheim Vetmedica) 
and, group III was kept as an unvaccinated control. Vaccines were used according to their  
licensed dosage.  
3.4. Sampling and PBMC Isolation 
Pigs were bled weekly in order to determine their serological status and to obtain peripheral blood 
mononuclear cells (PBMC) by means of a density-gradient centrifugation with Histopaque 1.077 
(Sigma). PBMC were routinely adjusted to a density of 5×10
6
 PBMC/ml in RPMI 1640 medium 
(Sigma) supplemented with 10% fetal bovine serum (FBS), 2 mM L-glutamine (Sigma) and 
antibiotics.  
3.5. IFN-γ ELISPOT 
The IFN-γ ELISPOT was carried out according to Diaz et al. [23] at 21, 49 and 56 dpv. Briefly, 
ELISA plates were coated overnight at 4 ºC with capture antibody P2G10 directed against porcine 
IFN-γ (BD Biosciences Pharmingen) diluted in 0.05 M carbonate-bicarbonate buffer pH 9.6.  
After washing with sterile PBS, 100 µl of PBMC were dispensed in plates (5 × 10
5
 per well) and were 
stimulated for 20 h with the genotype 1 or genotype 2 vaccine virus at a m.o.i. of 0.01 with the selected 
peptide at 10 μg/ml (as determined previously). The virus and peptides were added together.  
Un-stimulated PBMC and PHA-stimulated (10 μg/mL) cells were included as negative and positive 
controls, respectively. Each animal and assay was carried out in triplicate. After incubation, detection 
antibody P2C11 was dispensed into the wells and the ELISPOT assay was then revealed by the 
addition of insoluble TMB. In order to adjust antigen-speciﬁc frequencies of IFN-γ-producing cells 
(IFN-γ-SC), average counts of spots in un-stimulated wells were subtracted from average counts in 
antigen-stimulated wells. In the present case, results were expressed as the number of peptide-speciﬁc 
and PRRSV-speciﬁc IFN-γ-SC per 5x105 PBMC to reflect actual counts on plates. In order to further 
assure the speciﬁcity of the tests, adjusted counts ≤5 spots were considered to be non-signiﬁcant  
or inconclusive. 
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3.6. Cytokine ELISAs 
PBMC cultures (5x10
5
 PBMC/well) were stimulated with PHA, genotype 1 or genotype 2 PRRSV 
vaccine viruses at m.o.i. 0.1, peptides (10 µg/ml) or were mock-stimulated with culture medium for 
20 h. For these experiments, a peptide that has been previously suggested to have the potential for 
inducing Tregs (SNLQLIYNLTLCELNGTDWL) was also included [27]. Then, cell culture 
supernatants were collected and frozen at -80°C until used. TGF-β was quantified in the supernatants 
using a multispecies TGF-β kit and IL-10 was quantified using an in-house ELISA developed using 
appropriate antibody pairs (Invitrogen). In each plate a two-fold dilution series of cytokine standards 
provided by the manufacturer were included (from 2000 pg/mL to 31.25 pg/mL for IL-10 and  
from 4000 pg/ml to 62.5 pg/mL for TGF- β) plus a blank (0 pg/mL).  
To assure the specificity of the results, the cut-off of the ELISAs was calculated as the mean optical 
density plus three standard deviations of the blank sample. This value was compared with the average 
optical densities of the standard dilution series to determine the lower amount of cytokine that could be 
determined with precision. Then, for samples which optical densities were above the cut-off, cytokine 
concentrations were calculated using the correlation formula obtained from the cytokine standards. 
3.7. Inhibition of IFN-γ Responses by Peptides 
Peptides that did not induce IFN-γ and induced IL-10 response were further tested for their potential 
to inhibit IFN-γ responses. Two pigs of group I, one pig of group II and three pigs of group III were 
included. Inhibition of IFN-γ was examined by adding 10 µg/ml of the selected peptides to  
PHA-stimulated cells (5 × 10
4
; triplicates). IFN-γ production was evaluated by ELISPOT as above.  
3.8. Statistical Analysis 
Data were analyzed using the non-parametric Kruskal-Wallis and Conover-Inman tests performed 
with StatsDirect v2.7.8 (StatsDirect Ltd, UK). Graphic images were constructed with GraphPad Prism 
software v5. 
4. Conclusions  
The present work describes one peptide in nsp2 of PRRSV able to induce IFN-γ. In addition, we 
describe that nsp may contain regions resulting in IL-10 induction and, in some peptides, inhibition of 
IFN-γ responses. These data are relevant for the development of future vaccines. 
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